Plus Therapeutics
Plus Therapeutics is focused on developing innovative, targeted radiotherapeutics for adults & children with difficult-to-treat cancer. Leveraging novel drug formulations and technologies, our drugs are designed to deliver a single, safe and effective dose of radiation directly to the tumor
Basic Information
- Category: public company
- Founded: 2010
- Website: https://plustherapeutics.com/
Documented Facts
- Phone: 12109746900 (No linked source recorded for this statement.)
- Email: logomark-dark@1x.svg (No linked source recorded for this statement.)
- Industry (SIC): Instruments (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: PSTV (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Plus Therapeutics — Official Site (official)
- Plus Therapeutics on instagram (social)
- Plus Therapeutics on facebook (social)
- Plus Therapeutics on linkedin (social)
- PLUS THERAPEUTICS, INC. — SEC EDGAR (reference)
Citation Guidance
Explore public company profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Plus Therapeutics.
- Canonical profile: https://brandsource.ai/brands/plus-therapeutics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/plus-therapeutics/json-ld
- Citation profile API: https://brandsource.ai/api/brands/plus-therapeutics/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Plus Therapeutics is focused on developing innovative, targeted radiotherapeutics for adults & children with difficult-to-treat cancer. Leveraging novel drug formulations and technologies, our drugs are designed to deliver a single, safe and effective dose of radiation directly to the tumor
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 4 supporting sources linked.
- 5 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.